Source document or public record

FDA 510(k) K251879 — Sulopenem SPM 2 µg

FDA 510(k) index record K251879. Device: Sulopenem SPM 2 µg. Applicant as listed: Liofilchem. Decision date: 2025-08-12.

OtherU.S. Food and Drug Administration (FDA)2025-08-12

Source

"device_name": "Sulopenem SPM 2 µg"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K251879.

Device name: Sulopenem SPM 2 µg. Applicant as listed: Liofilchem.

Decision date: 2025-08-12. Decision wording: Substantially Equivalent.

Product code: JTN. Regulation: 21 CFR 866.1620. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.